Description of the medicine: Ropivacaine (Ropivacaine)
(S) -N- (2,6-Dimethylphenyl) -1-propyl-2-piperidinecarboxamide.
Synonym: Naropin, Naropin.
Applied with epidural anesthesia (including cesarean section, postoperative pain), as well as for infiltration and conduction anesthesia.
A 0.2% solution is used to relieve acute pain: 10-20 ml are injected epidurally at the lumbar level (0.02-0.04 g once (analgesia develops after 10-15 minutes and lasts Ѕ-1Ѕ h) and, if necessary (with an interval of at least 30 minutes) 10-15 ml or infusion in the postoperative period at a rate of 6-14 mg per hour; for infiltration and conduction anesthesia, 1-100 ml (0.002-0.02 g) is administered (analgesia develops after 1- 5 minutes and lasts 2-6 hours).
A 0.75% solution is used: for cesarean section operations, 15-20 ml are administered; for epidural anesthesia - at the thoracic and lumbar level, respectively 5-15 and 15-25 ml (the effect develops after 10-20 minutes and lasts 3-5 hours); for infiltration and conduction anesthesia - 1-30 ml (1-15 minutes and 2-6 hours, respectively); for blockade of the large nerve plexuses - 10-40 ml.
Possible side effects: fluctuations in blood pressure and heart rate, neuropathy, impaired spinal cord function, nausea, vomiting, chills, urinary retention, allergic reactions, etc.
The drug is contraindicated in the age of 12 years.
Release form: 0.2%; 0.75% and 1% solutions in bottles of 10 and 20 ml and 0.2% in sterile bags of 100 and 200 ml.